Who are Tracrium Preservative Free's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Bay Ntn 33893, Nimbex, Nimbex, Zemuron, Mivacron.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/atracurium.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Tracrium Preservative Free — Competitive Intelligence Brief

Tracrium Preservative Free (ATRACURIUM) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nondepolarizing Neuromuscular Blocker. Area: Neuroscience.

marketed Nondepolarizing Neuromuscular Blocker Neuronal acetylcholine receptor subunit alpha-3 Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Tracrium Preservative Free (ATRACURIUM).

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Tracrium Preservative Free TARGET	ATRACURIUM		marketed	Nondepolarizing Neuromuscular Blocker	Neuronal acetylcholine receptor subunit alpha-3	1983-01-01
Bay Ntn 33893	imidacloprid		marketed		Neuronal acetylcholine receptor subunit alpha-3, Acetylcholine receptor subunit beta-like 2, Acetylcholine-binding protein
Nimbex	Cisatracurium Besylate	AbbVie	marketed	Nondepolarizing Neuromuscular Blocker	Acetylcholine receptor	1995-01-01
Nimbex	CISATRACURIUM	AbbVie	marketed	Nondepolarizing Neuromuscular Blocker	Acetylcholine receptor	1995-01-01
Zemuron	ROCURONIUM	Fresenius Kabi	marketed	Nondepolarizing Neuromuscular Blocker	Acetylcholine receptor	1994-01-01
Mivacron	MIVACURIUM	AbbVie	marketed	Nondepolarizing Neuromuscular Blocker	Acetylcholine receptor	1992-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nondepolarizing Neuromuscular Blocker class)

AbbVie · 3 drugs in this class
· 1 drug in this class
Fresenius Kabi · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tracrium Preservative Free — Competitive Intelligence Brief. https://druglandscape.com/ci/atracurium. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab